Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Federal Trade Commission
Chinese Patent Office
Boehringer Ingelheim
Deloitte
Harvard Business School
Medtronic
Argus Health

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,409,212

« Back to Dashboard

Summary for Patent: 4,409,212
Title: Method of preventing and treating cerebral insufficiency
Abstract:The invention relates to a method of preventing or treating cerebral insufficiency, which method comprises administering to a human being in need of such treatment, orally or rectally, a prophylactic or a therapeutically effective amount of a compound of the general formula I ##STR1## wherein X.sub.1 is hydrogen, halogen having an atomic number up to 35, or is cyano, and X.sub.2 and Y together are an additional bond, or X.sub.1 and X.sub.2 together are the oxo radical and Y is hydrogen, or X.sub.1 is hydroxy and X.sub.2 and Y are hydrogen. Examples of suitable compounds are 10,11-dihyro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide and, in particular, carbamazepine (5H-dibenz[b,f]azepine-5-carboxamide).
Inventor(s): Mondadori; Cesare (Don Mills, CA)
Assignee: Ciba-Geigy Corporation (Ardsley, NY)
Application Number:06/366,792
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,409,212
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 4,409,212

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,409,212

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland2565/81Apr 16, 1981

International Family Members for US Patent 4,409,212

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 8263382 ➤ Try a Free Trial
Belgium 892882 ➤ Try a Free Trial
Switzerland 649080 ➤ Try a Free Trial
Italy 1147841 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
AstraZeneca
McKinsey
McKesson
Moodys
Queensland Health
US Department of Justice
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.